Tamarack Advisers, LP Bioventus Inc. Transaction History

Tamarack Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$6.82 - $13.82 $511,500 - $1.04 Million	-75,000 Reduced 9.09%	750,001 $5.12 Million
Q1 2022 May 11, 2022	SELL	$11.65 - $15.28 $582,488 - $763,984	-49,999 Reduced 5.71%	825,001 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.37 - $16.77 $4.89 Million - $6.62 Million	395,000 Added 82.29%	875,000 $12.7 Million
Q3 2021 Nov 12, 2021	BUY	$13.7 - $17.25 $68,500 - $86,250	5,000 Added 1.05%	480,000 $6.8 Million
Q2 2021 Aug 13, 2021	SELL	$13.75 - $18.8 $2.75 Million - $3.76 Million	-200,000 Reduced 29.63%	475,000 $8.36 Million
Q1 2021 May 12, 2021	BUY	$11.49 - $19.21 $7.76 Million - $13 Million	675,000 New	675,000 $10.3 Million

141

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $655M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.